![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-desktop-header-01gif-33629.gif)
![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-mob-header-01gif-17728.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2021/09/08/2293324/0/zh-hans/%E5%87%AF%E7%91%9E%E5%BA%B7%E5%AE%81%E5%90%AF%E5%8A%A8-XW10508%E9%A6%96%E6%AC%A1%E4%BA%BA%E4%BD%93%E8%AF%95%E9%AA%8C-%E5%BC%80%E5%8F%91%E5%BF%AB%E9%80%9F%E7%BC%93%E8%A7%A3%E9%9A%BE%E6%B2%BB%E6%80%A7%E6%8A%91%E9%83%81%E7%97%87%E5%92%8C%E6%85%A2%E6%80%A7%E7%96%BC%E7%97%9B%E7%9A%84%E8%8D%AF%E7%89%A9.html
https://www.biospace.com/article/releases/xwpharma-announces-positive-results-from-phase-1-clinical-trials-of-xw10172-in-development-as-once-nightly-therapy-for-sleep-disorders-in-patients-with-neurodegenerative-diseases/